AMGN  valuation analysis

Basics
Name: Amgen Inc
Description: Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. (more)
Industry: Drug Manufacturers-General
Last 10Q10Qs are quarterly reports which contain a company's financial figures. We use these to calculate the FFER.: Apr 27, 2022
Market cap: $139.41B (55th)
Sales(TTM): $26.32B (127th)
Earnings(TTM): $5.72B (82nd)

Value
FFER: 0.92 (why)
Actual price: $253.01
FFEThis is Amgen Inc's the estimated price. FFEs are the denominator of the FFER ratio.: $274.47
Quantile: AMGN is priced correctly given its fundamentals.
Prices as of EOD 2022-05-25
Price & Estimates
Sales & Earnings history (TTM)
Notable
No notables found through heuristics.
Earnings / MarketCap
Amgen Inc
"Drug Manufacturers-General" industry
Sales / MarketCap
Amgen Inc
"Drug Manufacturers-General" industry
Book / MarketCap
Amgen Inc
"Drug Manufacturers-General" industry
Equity / Assets
Amgen Inc
"Drug Manufacturers-General" industry